The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
Identifieur interne : 000960 ( Main/Corpus ); précédent : 000959; suivant : 000961The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
Auteurs : Felipe Ornell ; Helena Ferreira Moura ; Juliana Nichterwitz Scherer ; Flavio Pechansky ; Felix Henrique Paim Kessler ; Lisia Von DiemenSource :
- Psychiatry research [ 1872-7123 ] ; 2020.
Abstract
The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus.
DOI: 10.1016/j.psychres.2020.113096
PubMed: 32405115
PubMed Central: PMC7219362
Links to Exploration step
pubmed:32405115Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.</title><author><name sortKey="Ornell, Felipe" sort="Ornell, Felipe" uniqKey="Ornell F" first="Felipe" last="Ornell">Felipe Ornell</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Faculdade IBGEN, IBGEN Buzines School - Grupo Uniftec, Centro Universitário e Faculdades, Porto Alegre, RS, Brazil. Electronic address: fornell@hcpa.edu.br.</nlm:affiliation></affiliation></author><author><name sortKey="Moura, Helena Ferreira" sort="Moura, Helena Ferreira" uniqKey="Moura H" first="Helena Ferreira" last="Moura">Helena Ferreira Moura</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Scherer, Juliana Nichterwitz" sort="Scherer, Juliana Nichterwitz" uniqKey="Scherer J" first="Juliana Nichterwitz" last="Scherer">Juliana Nichterwitz Scherer</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Universidade do Vale do Rio dos Sinos, São Leopoldo, RS, Brasil.</nlm:affiliation></affiliation></author><author><name sortKey="Pechansky, Flavio" sort="Pechansky, Flavio" uniqKey="Pechansky F" first="Flavio" last="Pechansky">Flavio Pechansky</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Kessler, Felix Henrique Paim" sort="Kessler, Felix Henrique Paim" uniqKey="Kessler F" first="Felix Henrique Paim" last="Kessler">Felix Henrique Paim Kessler</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Von Diemen, Lisia" sort="Von Diemen, Lisia" uniqKey="Von Diemen L" first="Lisia" last="Von Diemen">Lisia Von Diemen</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Department of Psychiatry, Kingston General Hospital, Queen's University, Kingston, ON, Canada.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32405115</idno><idno type="pmid">32405115</idno><idno type="doi">10.1016/j.psychres.2020.113096</idno><idno type="pmc">PMC7219362</idno><idno type="wicri:Area/Main/Corpus">000960</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000960</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.</title><author><name sortKey="Ornell, Felipe" sort="Ornell, Felipe" uniqKey="Ornell F" first="Felipe" last="Ornell">Felipe Ornell</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Faculdade IBGEN, IBGEN Buzines School - Grupo Uniftec, Centro Universitário e Faculdades, Porto Alegre, RS, Brazil. Electronic address: fornell@hcpa.edu.br.</nlm:affiliation></affiliation></author><author><name sortKey="Moura, Helena Ferreira" sort="Moura, Helena Ferreira" uniqKey="Moura H" first="Helena Ferreira" last="Moura">Helena Ferreira Moura</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Scherer, Juliana Nichterwitz" sort="Scherer, Juliana Nichterwitz" uniqKey="Scherer J" first="Juliana Nichterwitz" last="Scherer">Juliana Nichterwitz Scherer</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Universidade do Vale do Rio dos Sinos, São Leopoldo, RS, Brasil.</nlm:affiliation></affiliation></author><author><name sortKey="Pechansky, Flavio" sort="Pechansky, Flavio" uniqKey="Pechansky F" first="Flavio" last="Pechansky">Flavio Pechansky</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Kessler, Felix Henrique Paim" sort="Kessler, Felix Henrique Paim" uniqKey="Kessler F" first="Felix Henrique Paim" last="Kessler">Felix Henrique Paim Kessler</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Von Diemen, Lisia" sort="Von Diemen, Lisia" uniqKey="Von Diemen L" first="Lisia" last="Von Diemen">Lisia Von Diemen</name><affiliation><nlm:affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Department of Psychiatry, Kingston General Hospital, Queen's University, Kingston, ON, Canada.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Psychiatry research</title><idno type="eISSN">1872-7123</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32405115</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>289</Volume><PubDate><Year>2020</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.</ArticleTitle><Pagination><MedlinePgn>113096</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(20)30903-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2020.113096</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has brought major challenges to healthcare systems and public health policies globally, as it requires novel treatment and prevention strategies to adapt for the impact of the pandemic. Individuals with substance user disorders (SUD) are at risk population for contamination due to multiple factors-attributable to their clinical, psychological and psychosocial conditions. Moreover, social and economic changes caused by the pandemic, along with the traditional difficulties regarding treatment access and adherence-will certainly worsen during this period, therefore aggravate their condition. In addition, this population are potential vectors of transmission. In that sense, specific strategies for prevention and treatment must be discussed. health care professionals dealing with SUD must be aware of the risks and challenges they will meet during and after the COVID-19 outbreak. Addiction care must be reinforced, instead of postponed, in order to avoid complications of both SUD and COVID-19 and to prevent the transmission of coronavirus.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ornell</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Faculdade IBGEN, IBGEN Buzines School - Grupo Uniftec, Centro Universitário e Faculdades, Porto Alegre, RS, Brazil. Electronic address: fornell@hcpa.edu.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Helena Ferreira</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Juliana Nichterwitz</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Universidade do Vale do Rio dos Sinos, São Leopoldo, RS, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pechansky</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Felix Henrique Paim</ForeName><Initials>FHP</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Diemen</LastName><ForeName>Lisia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Drug and Alcohol Research and Collaborating Center on Alcohol and Drugs, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Department of Psychiatry, Kingston General Hospital, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32405115</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2020.113096</ArticleId><ArticleId IdType="pii">113096</ArticleId><ArticleId IdType="pmc">PMC7219362</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Immunol. 2008 Jul 1;181(1):641-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18566431</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Pharmacol. 2020 Jan 14;10:1619</Citation><ArticleIdList><ArticleId IdType="pubmed">31992985</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2020;42(3):232-235</Citation><ArticleIdList><ArticleId IdType="pubmed">32267343</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2009 Apr;34(5):1198-208</Citation><ArticleIdList><ArticleId IdType="pubmed">18563062</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Subst Abuse. 2016;25(5):391-398</Citation><ArticleIdList><ArticleId IdType="pubmed">28373792</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2020 May;115(5):832-849</Citation><ArticleIdList><ArticleId IdType="pubmed">31692109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Addict Med. 2017 Mar/Apr;11(2):161-162</Citation><ArticleIdList><ArticleId IdType="pubmed">28301371</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2020 May 6;289:113069</Citation><ArticleIdList><ArticleId IdType="pubmed">32413707</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Environ Res Public Health. 2016 Jan 13;13(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">26771628</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Rev. 2014;35(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28366975</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Geriatr Med. 2014 Aug;30(3):629-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25037298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung India. 2019 Jul-Aug;36(4):370-371</Citation><ArticleIdList><ArticleId IdType="pubmed">31290432</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Sci Med. 2015 Apr;131:131-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25771482</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2018 Oct;113(10):1905-1926</Citation><ArticleIdList><ArticleId IdType="pubmed">29749059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2019 May 24;9(1):7847</Citation><ArticleIdList><ArticleId IdType="pubmed">31127176</ArticleId></ArticleIdList></Reference><Reference><Citation>Prehosp Disaster Med. 2020 Apr;35(2):119</Citation><ArticleIdList><ArticleId IdType="pubmed">32167445</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Public Health. 2018 Feb 1;28(1):150-155</Citation><ArticleIdList><ArticleId IdType="pubmed">29020390</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2020 Jun;133(6):657-663</Citation><ArticleIdList><ArticleId IdType="pubmed">32179055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000960 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000960 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32405115
|texte= The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32405115" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |